-+ 0.00%
-+ 0.00%
-+ 0.00%

Schrodinger’s Karen Akinsanya, therapeutics R&D head, disposes of USD 928,770 common shares

PUBT·09/21/2026 21:15:58
Listen to the news
Schrodinger’s Karen Akinsanya, therapeutics R&D head, disposes of USD 928,770 common shares
  • Schrodinger President Karen Akinsanya exercised stock options for 31,599 shares at $4.34 on Sept. 17, 2026.
  • She sold 31,599 shares the same day, including 10,000 at $28 and 21,599 at $30.
  • Directly held common stock position fell to 69,956 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schrodinger Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001797672-26-000006), on September 21, 2026, and is solely responsible for the information contained therein.